Its contribution is to provide scientific opinions on the efficacy, quality and safety of medicines being authorised for marketing in Europe.
PRESENTATION
Through its EMA focal point, the Public Research Centre for Health (CRP), has been providing support since 1995 to the Luxemburgish government and especially to the Pharmaceutical and Drugs Division (DPM) of the Health Ministry which fulfils the role of a Luxemburgish Drugs Agency, as well as to the Medicines Control Service of the National Health Laboratory, by providing experts able to participate in the activities of the European Medicines Agency.
At the same time, the EMA Focal Point also carries out evaluations for the WHO.